ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.

@article{Vastesaeger2014ASDASHD,
  title={ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.},
  author={Nathan Vastesaeger and Bert Vander Cruyssen and Juan Bartolome Mulero and Jordi Gratac{\'o}s Masmitj{\'a} and Pedro Zarco and Raquel Almod{\'o}var and Pilar Font and Xavier Juanola and E. Collantes-Estevez},
  journal={Reumatologia clinica},
  year={2014},
  volume={10 4},
  pages={204-9}
}
OBJECTIVE To investigate which of the 2 ankylosing spondylitis (AS) disease activity instruments identifies better those patients with characteristics that have been associated with positive response to anti-TNF therapy. METHODS Data from patients with AS in the REGISPONSER registry were analyzed. Patients were categorized by disease activity using 3 different selection criteria: elevated Bath Ankylosing Spondylitis Disease Activity Index criteria (BASDAI≥4), high Ankylosing Spondylitis… CONTINUE READING
5 Citations
17 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Documento SER de consenso sobre el uso de terapias biológicas en la espondilitis anquilosante y otras espondiloartritis, excepto la artritis psoriásica

  • X Juanola, P Zarco, J Sanz, S Muñoz-Fernández, J Mulero, LF Linares
  • 2011
1 Excerpt

umento SER de consenso sobre el uso de terapias biológicas en la espondilitis anquilosante y otras espondiloartritis , excepto la artritis psoriásica

  • X Juanola, P Zarco, J Sanz, S Muñoz-Fernández, J Mulero, LF Linares
  • Reumatol Clin
  • 2011

Similar Papers

Loading similar papers…